bromodeoxyuridine has been researched along with Liposarcoma, Myxoid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barone, MV; Crozat, A; Philipson, L; Ron, D; Tabaee, A | 1 |
1 other study(ies) available for bromodeoxyuridine and Liposarcoma, Myxoid
Article | Year |
---|---|
CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Bromodeoxyuridine; CCAAT-Enhancer-Binding Proteins; DNA Damage; DNA-Binding Proteins; G1 Phase; Genetic Variation; Humans; Leucine Zippers; Liposarcoma, Myxoid; Mice; Molecular Sequence Data; Mutation; Nuclear Proteins; Oncogene Proteins; S Phase; Transcription Factor CHOP; Transcription Factors | 1994 |